Walz, A.; Duffey, M.; Aljayyoussi, G.; Sax, S.; Leroy, D.; Besson, D.; Burrows, J.N.; Cherkaoui-Rbati, M.H.; Gobeau, N.; Westwood, M.-A.;
et al. The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro. Pharmaceuticals 2023, 16, 163.
https://doi.org/10.3390/ph16020163
AMA Style
Walz A, Duffey M, Aljayyoussi G, Sax S, Leroy D, Besson D, Burrows JN, Cherkaoui-Rbati MH, Gobeau N, Westwood M-A,
et al. The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro. Pharmaceuticals. 2023; 16(2):163.
https://doi.org/10.3390/ph16020163
Chicago/Turabian Style
Walz, Annabelle, Maëlle Duffey, Ghaith Aljayyoussi, Sibylle Sax, Didier Leroy, Dominique Besson, Jeremy N. Burrows, Mohammed H. Cherkaoui-Rbati, Nathalie Gobeau, Marie-Anne Westwood,
and et al. 2023. "The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro" Pharmaceuticals 16, no. 2: 163.
https://doi.org/10.3390/ph16020163
APA Style
Walz, A., Duffey, M., Aljayyoussi, G., Sax, S., Leroy, D., Besson, D., Burrows, J. N., Cherkaoui-Rbati, M. H., Gobeau, N., Westwood, M. -A., Siethoff, C., Gamo, F. -J., Mäser, P., & Wittlin, S.
(2023). The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro. Pharmaceuticals, 16(2), 163.
https://doi.org/10.3390/ph16020163